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Abstract
A 66-year-old female patient without any relevant medical history other than rectal cancer was admitted for biopsy of 
a peri-myocardial tumor after the incidental finding of a mass in the region of the ventral right ventricle in a follow-
up positron emission tomography with computed tomography (PET-CT). Diagnostic investigation revealed a cardiac 
metastasis of the rectal cancer affecting the anterior right ventricle, obstructing the right ventricular outflow tract, and 
causing a type 1 Brugada ECG.
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Introduction
Obvious cardiac metastases are rare. The reported incidence in 
autopsies of patients with malignant neoplasms ranges from 2% to 
20%. Colon carcinoma is responsible for 1.2% of all secondary cardiac 
tumors [1]. Clinical presentations of cardiac metastases are variable 
and depend on the localization of the tumor. In intramyocardial 
tumors, arrhythmia is the leading presentation. With progression 
of infiltration, diastolic and systolic dysfunction may develop. ECG 
changes in patients with cardiac metastases are unspecific and usually 
show signs of pericardial effusion or myocardial ischemia [2]. ECG 
changes however, particularly changes in the ST segment and T wave, 
are highly suggestive of cardiac involvement in patients with neoplasia 
if reversible causes, as ischemia and peri-myocarditis are excluded [3].
Case Presentation
A 66 year-old female without any relevant medical history other 
than a rectal carcinoma (T3N0M0) that was surgically completely 
removed 6 months earlier, was admitted for a computed tomography 
(CT) guided biopsy (Figure 1) of a mass located in the peri-myocardial 
region of the right ventricular outflow tract (RVOT). A previously 
positron emission tomography performed for follow-up of colonic 
surgery confirmed a metabolically active tumor. Based on imaging, 
it was not possible to determine whether the mass was located in the 
pericardium or myocardium.
At the current hospital admission, the patient was free of any 
symptoms. Particularly, the patient’s history was negative for 
syncope, palpitations and chest pain. The family history was negative 
for sudden cardiac death, arrhythmia or stillbirth. The physical 
examination was unrevealing.
The ECG at admission showed an elevated J-point of 0.25 mV 
(2.5 mm), a coved ST-segment elevation and a negative T wave in 
lead V1, and T-wave inversions in V2 to V4. The Corrado index 
[3] was 1.2 in V1, consistent with type 1 Brugada ECG [4] (Figure 
2). An ECG performed six months earlier, prior to diagnosis of the 
tumor in the right ventricle, showed an rSr’ pattern and neither ST 
element elevation in V1 nor unequivocally negative T waves in V1 to 
V4 (Figure 3).
A needle biopsy of the mass was performed, and the 
histopathologic examination was consistent with partially necrotized 
tissue. Immunohistochemistry was positive for cytokeratin and p63, 
consistent with a metastasis of the rectal carcinoma. Immediately 
after the cardiac biopsy, a hemodynamic unstable wide complex 
tachycardia, most likely ventricular tachycardia, occurred 
necessitating electrical cardioversion.
The follow-up PET-CT also showed several new hyperdense 
lesions in the lungs, consistent with pulmonary metastases. Removal 
of the peri-myocardial mass was considered to be of an unfavorable 
risk-benefit ratio, and a palliative treatment strategy was chosen 
in view of the poor prognosis. The Type 1 Brugada ECG pattern 
persisted during follow-up ECG recordings.
Discussion
The case presented here demonstrates a newly developed Brugada 
type 1 ECG in a patient with a cardiac metastasis of a rectal carcinoma.
The ECG performed 6 months prior to the diagnosis of the right 
ventricular metastasis showed an rSr’ configuration in V1 without 
meeting the criteria for complete right bundle block [5] or any criteria 
for a Brugada pattern. According to a current consensus report for 
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electrocardiographic criteria of Brugada ECG pattern [6], this rSr’ 
finding cannot be interpreted as early stage of a Brugada pattern due 
to the peaked positive terminal r' and the identical QRS duration in 
V1 and V6.
The ECG performed during the current hospitalization fulfilled 
all criteria of a type 1 ECG pattern, showing a typical ST elevation 
of 2.5 mm and a coved ST segment with T-wave inversion in V1. 
The Corrado index [3], distinguishing between Brugada pattern and 
other pathologies with ST-elevations mimicking a Brugada pattern, 
was also positive.
Following to the guidelines of the European Society of Cardiology 
for the management of patients with ventricular arrhythmias and the 
prevention of sudden cardiac death [4], and the consensus statement 
on the diagnosis and management of patients with inherited primary 
arrhythmia syndromes [7], the ECG alone is sufficient for the 
diagnosis of a Brugada syndrome. However, in our patient, we have 
to interpret the ECG findings as a Brugada phenocopy [8]. Anselm, 
et al. published criteria to identify Brugada phenocopies, which 
include reversibility of the pattern after removal or disappearance of 
the provoking factor. There are case reports of extra-cardiac tumor 
compressing the RVOT. With removal of the tumor, the Brugada 
         
Figure 2: Standard resting 12-lead ECG at the current presentation. The precordial lead V1 shows an elevated J-point of 0.25 mV with an elevated 
coved ST segment a negative T-wave. T-wave inversions are visible in V2 to V4. These findings are consistent with a type 1 Brugada ECG.
         
Figure 1: Computed tomography scan of the chest. The asterisk marks the tumor mass. RV = right ventricle, and LV = left ventricle.
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pattern disappeared [9,10]. In our patient, a proof of Brugada 
phenocopy is missing because reversibility could not be shown. Thus 
a diagnosis of a Brugada phenocopy cannot be achieved based on 
these criteria [8]. However, the evolution of the ECG changes over 
time, the patient’s history, and the localization of the mass in the right 
ventricular wall are highly suggestive for a Brugada phenocopy.
Patients with a Brugada phenocopy due to RVOT compression 
were described previously [10]. However, to our knowledge, this is 
the first reported case of a probable Brugada phenocopy secondary to 
a cardiac metastasis.
The pathophysiological evolution of the Brugada pattern by 
compression of the RVOT remains poorly understood. Alterations 
in the transmural repolarization gradient by the metastasis may 
contribute to this pattern [11].
The limitation of this case report is that it was not possible to 
proof a Brugada phenocopy based on published criteria. This is a 
well-known “diagnostic dilemma” [12]. However, considering the 
evolution of ECG in combination with the finding of an RVOT 
compression due to a cardiac metastasis, and the missing personal 
and family history for a Brugada syndrome strongly supports the 
hypothesis of a Brugada phenocopy.
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Figure 3: Standard resting 12-lead ECG 6 months before the current presentation without Brugada pattern.
